INMD Stock - InMode Ltd.
Unlock GoAI Insights for INMD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $394.82M | $492.05M | $454.27M | $357.56M | $206.11M |
| Gross Profit | $317.07M | $411.34M | $380.79M | $303.97M | $175.26M |
| Gross Margin | 80.3% | 83.6% | 83.8% | 85.0% | 85.0% |
| Operating Income | $112.53M | $195.66M | $197.85M | $167.48M | $72.84M |
| Net Income | $181.28M | $197.92M | $161.52M | $164.97M | $75.03M |
| Net Margin | 45.9% | 40.2% | 35.6% | 46.1% | 36.4% |
| EPS | $2.29 | $2.37 | $1.96 | $2.03 | $1.04 |
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
Visit WebsiteEarnings History & Surprises
INMDEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q1 2026 | Feb 3, 2026 | $0.42 | — | — | — |
Q4 2025 | Nov 5, 2025 | $0.35 | $0.38 | +8.3% | ✓ BEAT |
Q3 2025 | Jul 30, 2025 | $0.43 | $0.47 | +9.3% | ✓ BEAT |
Q2 2025 | Apr 28, 2025 | $0.33 | $0.31 | -6.1% | ✗ MISS |
Q1 2025 | Feb 4, 2025 | $0.50 | $0.42 | -16.0% | ✗ MISS |
Q4 2024 | Oct 30, 2024 | $0.63 | $0.70 | +11.1% | ✓ BEAT |
Q3 2024 | Aug 1, 2024 | $0.38 | $0.34 | -10.5% | ✗ MISS |
Q2 2024 | May 2, 2024 | $0.41 | $0.32 | -22.0% | ✗ MISS |
Q1 2024 | Feb 13, 2024 | $0.67 | $0.71 | +6.0% | ✓ BEAT |
Q4 2023 | Nov 2, 2023 | $0.64 | $0.61 | -4.7% | ✗ MISS |
Q3 2023 | Jul 27, 2023 | $0.64 | $0.72 | +12.5% | ✓ BEAT |
Q2 2023 | May 2, 2023 | $0.47 | $0.52 | +10.6% | ✓ BEAT |
Q1 2023 | Feb 14, 2023 | $0.74 | $0.78 | +5.4% | ✓ BEAT |
Q4 2022 | Oct 27, 2022 | $0.58 | $0.66 | +13.8% | ✓ BEAT |
Q3 2022 | Jul 28, 2022 | $0.51 | $0.59 | +15.7% | ✓ BEAT |
Q2 2022 | May 2, 2022 | $0.38 | $0.40 | +5.3% | ✓ BEAT |
Q1 2022 | Feb 10, 2022 | $0.56 | $0.64 | +14.3% | ✓ BEAT |
Q4 2021 | Oct 26, 2021 | $0.50 | $0.55 | +10.0% | ✓ BEAT |
Q3 2021 | Jul 28, 2021 | $0.43 | $0.51 | +18.6% | ✓ BEAT |
Latest News
Frequently Asked Questions about INMD
What is INMD's current stock price?
What is the analyst price target for INMD?
What sector is InMode Ltd. in?
What is INMD's market cap?
Does INMD pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to INMD for comparison